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ABSTRACT 
The liver is responsible for several functions in the body including performing and controlling the homeostasis as well as nu trient and energy 
supply, metabolism and growth. It activates and inactivates exogenous and endogenous xenobiotics due to it has a defense mechanism but this 
sometimes inadequate, resulting in pathological conditions that influence the function and structure of the liver compartment leading to 
pathophysiological changes which may results in hepatotoxicity. It is the main reason for withdrawing of some drugs from marketing. 
Antioxidants are the substances those are present at low levels and significantly delay or prevent oxidation of the oxidizable substrate. They are 
one solution for controlling the hepatotoxicity. It is necessary to obtain a comprehensive article giving us overview information about 
hepatotoxicity and antioxidants relationship. 
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1. INTRODUCTION 
Liver is the main internal organ and gland amongst the most 
important and complex organs, representing about 2.5% of 
an adult body weight. It's formed from parenchymal cells 
(hepatocytes) and non-parenchymal cells (Sinusoidal 
endothelial cells, kupffer cells and hepatic stellate cells). It 
occupies the upper right part of the abdominal cavity and 
underneath the diaphragm. It is connected to hepatic artery 
and hepatic portal vein. In fact, during rest it receives about 
25% of the cardiac output through hepatic artery and hepatic 
portal vein. The hepatic portal vein carries the absorbed 
blood containing nutrients, toxins, and other substances 
from the gastrointestinal tract (duodenum) to the liver. The 
liver filters this blood, after that sends it via the hepatic vein 
to the heart in order to pump it all over the body [1].  
It often performs a central function in more than 500 bodily 
functions via oxidation, reduction, hydration, hydrolysis, 
condensation, conjugation, or isomerization [2, 3]. Scientists 
suppose that, the liver is related to every dysfunction or 
disease and acts as the laboratory of the body [4]. Actually, it 
is the chief site for intense biotransformation and excretion 
[5]. Liver adjusts production, storage, and release of fats, 
sugar and cholesterol. It stores numerous nutrients, 
including vitamins A, D, B12 and K along with iron and copper 
and converts iron into heme according to body 
requirements. Besides, it synthesizes several important 
hormones (angiotensinogen, insulin-like growth factor1, 
thrombopoietin and glycoprotein),clotting factors 
(fibrinogen, prothrombin and antithrombin), enzyme 
catalase and immune factors [6,7]. Moreover, hepatocytes  
produce and excrete bile fluid (consists of water, bile salts, 
cholesterol, a phospholipid called lecithin, bile pigments and 
several ions) that helps digestion of fats, absorption of fat-
soluble nutrients and serves as a filter that detaches out toxic 
substances from blood stream [8].  
In addition hepatic cells are imperative for the metabolism, 
detoxification and activation of endogenous (reactive 
oxygen/nitrogen species, saturated fatty acids, cholesterol, 
oxysterols, isoprostanes, eicosanoids and 
lipopolysaccharide) and exogenous substances (over the 
counter medications, prescription medications, parasites, 
bacteria, viruses, heavy metals, pesticides and food 
preservatives) in existence of various enzymes. Actually, the 
essential role played by liver in the transformation and 
clearance of toxins exposes it to hurt and induce 
hepatotoxicity[9, 10].  
Agents which cause hepatotoxicity are named 
hepatotoxinsor hepatotoxicants[7]. Any damage to liver or 
disturbance of its functions might result in many 
implications on one’s health [11]. The leading cause of drug 
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non-approval and drug withdrawal by the Food and Drug 
Administration (FDA) in the US is drug-induced 
hepatotoxicity [9, 12]. More than a thousand medicines and 
chemicals have been accounted to cause liver injury [13]. 
Drug-induced liver injury may account for about 10% of all 
cases of acute hepatitis, 5% of all hospital permissions, and 
50% of all acute liver failures [12]. It is remarkable that more 
than 75% of cases of idiosyncratic drug reactions result in 
liver transplantation or death [9]. Drug-induced liver injury 
is a somewhat common cause of acute liver disease and 
carries a mortality of around 10% [14] 
So, maintainance of a healthy liver is a vital factor for the 
overall health and wellbeing [15]. According to Ghori et al. 
hepatotoxicants damage hepatocytes mainly by inducing 
lipid peroxidation and further oxidative damages in the liver 
due to chronic treatment or toxic doses resulting in death 
[16]. The liver is a chief target organ of the toxicity of 
xenobiotics, drugs, and oxidative stress resulting from its 
association to the gastrointestinal tract and unique 
metabolism [10]. The gut–liver relationship plays an 
important part in drug-induced liver injury owing to 
increasing the production of cytokines, arachidonic fatty acid 
metabolites and reactive oxygen species (ROS) in the 
hepatocytes resulting from increasing of hepatic endotoxin 
influx [17]. Thus, liver injury and disease are still the 
foremost global health problems[18]. There are different 
factors that improve a person’s susceptibility to a potentially 
hepatotoxic drug [14] and they are represented in Figure (1). 
 
 
Figure 1: Factors affecting drug induced hepatictoxicity. 
 
2. Pathogenesis of the hepatotoxicity 
Drugs and xenobiotic in the liver are in concentrated form 
because around 75% blood which enters liver by portal vein 
comes from spleen and gastrointestinal canal. The basic role 
of the liver is converting of the chemical substance from 
lipophilic form to hydrophilic form to be easily excreted. 
Enzymatic metabolism in the liver carried out by cytochrome 
P-450, the main metabolizing enzymes system which is 
situated in the endoplasmic reticulum of the hepatocytes 
[19]. Liver damage results from synthesis of reactive 
metabolites from drugs. They have an ability to interact with 
macromolecules of hepatocyte for instance nucleic acids, 
lipids, proteins and carbohydrates leading to oxidative stress 
due to DNA damage, lipid peroxidation and protein 
dysfunction [20]. 
2.a. Mitochondria  
Mitochondria are multifunctional organelles liable mainly for 
production of energy in the form of ATP from ADP in what is 
called oxidative phosphorylation [21], and mitochondrial 
role involved in intracellular stress cascades,  apoptosis and 
necrosis or death[22, 23]. Mitochondria of the cell carry the 
electron transport chain that reduces oxygen to water by 
addition of electrons during oxidative phosphorylation. 
Mitochondria are the basic source of endogenous ROS. It is 
elicited that the production of endogenous ROS within 
human mitochondrion is about 107 molecules/day 
throughout normal oxidative phoshorylation[24]. ROS 
induce more persistent damage to mitochondrial DNA than 
to nuclear DNA [25]. High levels of intracellular ROS related 
to depletion of GSH, oxidation or alkylation of protein, 
binding to enzymes or nucleic acids, peroxidation of lipid, 
and respiratory chain changes are accompanied by 
mitochondrial dysfunction. These events are the major 
reasons for liver diseases and drug induced liver injury [26]. 
Moreover, parent drug or drug reactive metabolites, after the 
biotransformation with Phase I (oxidation, reduction, 
hydroxylation and de-methylation) or Phase II (conjugation 
of chemicals conjugate with hydrophilic moieties) enzymes, 
can provoke hepatitis through immune reactions or direct 
toxicity causing mitochondrial membrane disruption [27]. 
Drug or its reactive metabolites covalently bind to human 
leukocyte antigen (HLA) proteins as a carrier forming 
hapten, which is exposed to cytotoxic T-Lymphocytes and 
recognized as antigens. Antigens are presented on antigen 
presenting cells to stimulate synthesis of antibodies against 
themselves or initiate the specific immune system forming 
auto-antibodies against cell organelles [28, 29]. Danger 
signals are necessary for immunological reactions [30]. 
These signals initiate signal pathways for oxidative stress 
resulting in immune-mediated hepatocyte damage. The 
signal may be a separate drug, viruses, bacteria or a cytokine 
results from an inflammatory reaction [31, 32]. 
2.b. Endoplasmic reticulum 
Endoplasmic reticulum (ER) is a main intracellular organelle 
in controlling of protein synthesis, folding, modification, and 
trafficking. In addition to these, the ER has a critical function 
in calcium maintenance and in regulating carbohydrates, 
steroids and lipids biosynthesis[33]. In the ER lumen the 
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concentration of oxidized glutathione (GSSG) is more than 
reduced glutathione (GSH) creating oxidizing environment 
that promotes formation of disulfide bond [34]. ER is the 
major site for producing of ROS from formation of disulphide 
bond through oxidative protein folding [35]. Excessive 
accumulation of folding protein results in consumption of 
reduced glutathione owing to unstable disulphide 
bonds[36].Leakage of calcium from ER in response to 
oxidative injury and stress, resulting in aggregation of 
calcium in mitochondria stimulating mitochondrial ROS [37]. 
Notably, several pathological  and physiological conditions 
can suppress normal protein folding leading to disturbances 
of ER homeostasis such as redox disturbances, glucose 
starvation, energy depletion, alterations of ER luminal 
calcium stores, viruses, xenobiotics, lipid accumulation as 
well as ethanol intoxication [38-40] ER suppress results in 
stimulation of unfolded protein response (UPR), activates 
autophagy and proteasome-dependent proteolysis[41-43]. 
2.c. Lysosome 
Lysosomeis a membrane-enclosed spherical cytoplasmic 
vesicles containing acidic (pH 4-5)hydrolytic lysosomal 
enzymes, theirmain roles arerecycling and disposal of worn-
out and damaged cytoplasmic  macromolecules and 
organelles (degradation of polysaccharides, proteins, and 
complex lipids into their corresponding structural units 
respectively: monosaccharides, amino acids (AAs), and free 
fatty acids [44, 45]. The byproducts of lysosomal 
degradation, via specialized exporters [46] or via vesicular 
membrane diffusion for new biosynthesis pathway or energy 
metabolism [47]. In addition to the digestion of extracellular 
and foreign materials transmitted to them by phagocytosis, 
endocytosis, or autophagy[48, 49], found in all animal cells 
except red blood cells[50]. 
Over 60 hydrolytic luminal lysosomal enzymes (proteases, 
sulfatases, phosphatases, glycosidases, lipases, and 
nucleases) perform the digestion of the load and extra 
lysosomal roles such as apoptosis, repair of cell membrane, 
and tissue remodeling [51, 52, 53, 54]. Iron accumulation is 
the main source of oxidative stress in the hepatocytes, since 
hepatocytes and Kupffer cells are the main cell types exposed 
to iron storage in the liver. Iron is a main constituent of iron-
sulfur containing enzymes, oxygen transport systems, and 
oxygen sensing proteins. The major site of iron storage are 
lysosomes, through transferrin mediated endocytosis goes 
into the hepatocyte, thenacidification of endosome, reduction 
of iron, and liberation from transferrin escaping into the 
cytosol.Notably, aggregation of Fe2+ is responsible for 
formation of ROS having a critical role for cellular 
compartment damage leading to injuries of cells and organs.  
Virtually, liver diseases, as human diseases, are related 
biochemically to ferritin level elevation in serum resulting 
from hepatocyte damage. Raised ferritin uptake into 
hepatocytes induces biological disturbances and promotes 
lipid peroxidation, reduction of GSH/GSSG ratio and 
depletion of GSH. Ferritin accumulation stimulates 
macroautophagy which is completed by chelation of Fe [55]. 
Increased lysosomal membrane permeability results in 
escaping of Fe2+ into the cytosol, in addition, reduction of 
Fe3+ by superoxide, supportsthe synthesis of ROS enhances 
peroxidation of cell membrane and cellular damage [56]. 
3. Hepatotoxicants 
1- Chemical-induced hepatotoxicity includes carbon 
tetrachloride, thioacetamide, diethylnitrosamine, 
aflatoxin B1, bromobenzene, lithocholic acid, acryl 
amide, acrolein, alpha-naphthylisothiocyanate, and d-
galactosamine. The products of the metabolism of these 
chemicals result in hepatocytes damage by cell 
shrinkage, nuclear apoptosis or swelling and necrosis 
due to direct effect on nucleus, mitochondria, 
cytoskeleton, and ER [57]. 
2- Drug-induced hepatotoxicity, these drugs establish 
their toxicity either by direct effect cellular organelles 
(non- steroidal anti-inflammatory drugs (diclofenac), 
paracetamol, anti-cancer, Azathioprine, and 
Adriamycin) or indirect by mediators (ranitidine, 
rifampicin, isoniazid, pyrazinamide, erythromycin, 
halothane, and tamoxifen) [58-61]. 
3- Metal-induced hepatotoxicityencloses members such as 
Mercury, Cadmium, and Lead [62- 64]. 
4- Phytotoxin induced hepatotoxicity implicates harmful 
substances as Phallotoxin, Microcystine, and 
Pyrrolizidine alkaloids [65, 66]. 
5- High fat diet induces hepatotoxicity due to stimulation 
of steatosis [67]. 
4. Hepatotoxicity biomarkers 
A- Hepatocytes injury biomarkers  
1-Alanine aminotransferase (ALA) 
     In fact, ALT is completely cytoplasmic enzyme which 
catalyzes the reaction of transamination. It is present in 
various body tissues (kidney, heart, and muscle) andplasma, 
but is available in large quantities in the cytosol of 
hepatocytes compared with other tissues[68]. ALT was 
previously known as serum glutamate (glutamic)-pyruvate 
(pyruvic) transaminase [69]. ALT is responsible for 
transferring of an amino group from L-alanine to α-
ketoglutarate, in reversible reaction forming pyruvate and L-
glutamate.  
L-alanine + α-ketoglutarate⇌pyruvate + L-glutamate 
Actually, ALT is widely used as a serum biomarker of 
hepatocellular injury, but can be elevated due to injury of 
heart tissue or skeletal muscle, or in response to some 
medications that do not cause liver injury however; ALT is 
estimated clinically as a part of a diagnosis of hepatocellular 
injury. Therefore, other serum hepatotoxicity biomarkers are 
required[70,71]. Clear elevations of ALT levels in blood 
serum observed usually in persons with toxin-induced liver 
injury[72]. 
2-Aspartate aminotransferase (AST) 
Regarding AST, it is a mitochondrial and cytoplasmic enzyme 
mainly present in the liver, heart, skeletal muscles, kidney, 
pancreas, erythrocytes, lungs and brain tissues. It 
participates in the transamination (metabolism) of aspartate 
[73].  Levels of serum AST, after cell damage, elevate within 
eight hours and reach the peak at 24-36 hours, then return to 
the normal rangewithin three to seven days. Notably, chronic 
cell injury results in levels of AST stayrose. AST is used with 
other enzymes for monitoring the causative agent of liver 
diseases, for example, with ALT for diagnosis of liver 
cirrhosis and alcoholic hepatitis [74]. Marked elevation of 
mitochondrial AST observed in severe chronic liver 
degeneration and necrosis [75]. The ratio between 
mitochondrial AST and total AST activity has an important 
diagnostic value in differentiation between alcoholic 
hepatitis and hepatocytes necrotic type [76]. 
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B-Cholestasis indicators 
1- Alkaline phosphatase (ALP) 
Essentially, ALP is a membrane-binding enzyme in mucosal 
epithelial cells of small intestine, liver, proximal convoluted 
tubules of kidney, placenta, and bone. It is responsible for 
lipid transportation in the intestine and bone calcification in 
bone. ALP stimulates certain reactions particularly, 
phosphate group hydrolysis from an organic molecule at an 
alkaline media [77, 78]. If ALP is present in high 
concentration in blood serum, this refers to liver or bone 
diseases or tumor [79]. Generally, the lining cells of the bile 
ducts produce the ALP as a primarily enzyme in cholestatic 
diseases due to granulomatous inflammation, tumor, benign 
familial hyperphosphatasemia, pancreatitis, abscesses, 
pregnancy (3rd trimester), osteomalacia, and duodenitis 
resulting in ALP evading into blood stream [80]. Alcoholic 
hepatitis plus drug or xenobiotic hepatitis induced increase 
of ALP levels attain to three times more than the normal 
range [81].  
2- γ-glutamyltranspeptidase (γGT) 
Actually, γGT is microsomal, cytoplasmic enzyme found in 
liver cells, epithelial lining cells of the bile duct, intestine, 
renal tubules and pancreas as well as bound to membranes. 
It takes part in transferring of amino acids across the 
cytoplasmic membrane and in metabolism of glutathione. It 
splits glutamyl groups and carries them to peptide chains 
and receptors. It is indicator for cholestasis. It may be used in 
combination with ALP for diagnosis of hepatobiliary and 
bone disease. γGT could be related to metabolism of 
glutathione. It intercedes the absorption of glutathione from 
extracellular to intracellular portion which is an important 
component of cells against oxidative stress [82]. It is an early 
biomarker of oxidative stress while; serum antioxidant 
carotenoids (β-carotene, α-carotene, β-cryptoxanthin, and 
lycopene) are correlated with heavy and moderate alcohol 
drinkers[83]. Levels of serum γGT reach higher than 10 
times of the upper values. It is partially regarding to hepatic 
injuries, induction of liver microsomal enzymes or pancreatic 
damages due to alcoholism [84].  
3 -5’ Nucleotidase [5'‐NT]  
Indeed, 5′-Nucleotidase (5’-NT) is an essential membrane 
glycoprotein enzyme in a large variety of body cells. It 
stimulates the hydrolysis reaction of the phosphate group of 
5’-nucleotides, leading to identical nucleosides. In spite of  5’-
NT  is widely distributed all over the human body, its marked 
elevations of 5’-NT  are practically necessary  for identifying 
biliary disorders, hepatitis, cholestatic liver disease, liver 
malignancy, biliary cirrhosis and intrinsic liver damage[85]. 
C-Biomarkers of the ability of the liver to transport 
organic anions and biotransformation of drugs 
1- Serum bilirubin 
Bilirubin (BR) is an endogenous anion results from 
degradation of haemoglobin within the macrophage or 
reticuloendothelial system, produced in unconjugated form 
which directs into the hepatocytes altering it by UDP-
glucuronyl transferase to conjugated BR[68]. BR in body is a 
sensitive equilibrium between the pigment synthesis and 
removal in body. The clinical sign of Jaundice appears when 
BR be observable in mucous membranes, the skin, and sclera 
resulting from over production, and declined hepatic uptake 
or conjugation of RB or both [86, 87]. The elevated levels of 
the conjugated BR are seen in hepatocellular damage, viral 
hepatitis, and ischemic or toxic liver injury [75]. 
2- Urine bilirubin 
Bilirubin in urine refers to hepatobiliary disorder. Normally, 
unconjugated form of bilirubin is strongly tied with albumin 
protein therefore; it is not excreted by the glomerular 
filtration resulting in unconjugated bilirubin not found in 
urine. The detectable quantity of bilirubin in blood serum is 
specific to hepatobiliarry disease. Notably, the renal 
threshold for conjugated bilirubin is small, so this, urine 
conjugated bilirubin form may be detected though the serum 
bilirubin levels are normal [88, 89]. 
3- Urobilinogen 
Hepatocellular dysfunctions for instance alcoholic liver 
injury and malignant disease or well compensated cirrhosis 
of the liver are well detected with an raise in the 
urobilinogen in urine [90, 91]. 
D- Biomarkers of the liver's biosynthetic ability 
1-Albumin 
Noteworthy, albumin is the highest plasma protein 
synthesized in the liver and is the indicator for the hepatic 
efficiency as well as it is synthesized lone in the liver 
[92].Albumin synthesis is stimulated via thyroid hormone 
and Corticosteroids [93]. In addition, its synthesis is 
controlled by liver disease, hormonal equilibrium, nutritional 
status, and osmotic pressure. The serum albumin readings 
are decreased in cirrhotic and ascetic patient [94]. 
2-Prealbumin 
Measurement of prealbumin (PA) protein particularly has 
benefits in diagnosis of drug-induced liver injuries [75]. PA is 
a form of plasma protein formed by the liver cells. Its 
biological half-life is short. The basic role of PA is 
transportation of vitamin A and thyroxine hormone for 
maturation of lymphocytes in order to stimulate resistance 
of the body [95]. The levels of PA are indicator and 
correlated with hepatocytes harm [96, 97]. 
 Noteworthy, in biology system, oxygen based radicals and 
nitrogen based radicals are two types of free radicals. Free 
radicals are atoms or molecules that have unpaired 
electrons, usually unstable and very reactive [98]. Oxidative 
stress, termed as an inequality between production and 
elimination of ROS leading to plural oxidative modifications 
of basic and regulatory methods, can be caused in dissimilar 
ways.  ROS is a combined term used for a group of oxidants, 
which are either free radicals or molecular species talented 
of generating free radicals Table (1)[99]. An oxygen molecule 
(O2) undergoes four-electron decrease when it is 
metabolized in vivo. During this process, reactive oxygen 
metabolites are created by the excitation of electrons 
secondary to addition of energy or interaction with 
transition elements. The reactive oxygen metabolites thus 
produced are more highly reactive than the original oxygen 
molecule and are called active oxygen species. In fact, 
superoxide (O2-.), hydrogen peroxide (H2O2), hydroxyl 
radicals (OH.), and singlet oxygen (O2) are the main examples 
of active oxygen species [100]. Indeed, ROS cause protein 
unfolding, collagen disintegration, lipid breakdown, DNA 
damage and fragmentation [101]. 
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Table (1): Reactive Oxygen Species (ROS); List of radicals 
and non-radicals molecules. 
Radicals                                         Non radicals 
OH.(Hydroxyl radical)                O2 (Singlet oxygen) 
O2-.(Superoxide radical)            H2O2 (Hydrogen peroxide) 
RO2.(Peroxyl radical)                  HOCl (Hypochlorous acid) 
RS.( Thyl radical)                         O3 (Ozone) 
RO.(Alkoxyl radical)                   LOOH (Lipid peroxide) 
LOO.(Lipid peroxyl) 
 
Oxidative Stress in Liver Diseases  
1. Oxidative Stress Caused by Alcohol 
It was reported that alcohol consumption accounting for an 
estimated 3.8% of global mortality. Alcoholic liver disease 
(ALD) is one of the most important causes of liver-related 
death, which is related with increased dose and time of 
alcohol ingestion. ALD may progress from steatosis to 
further severe liver diseases form, such as hepatitis, fibrosis, 
and cirrhosis [102, 103]. Although pathogenesis of ALD has 
not been entirely elaborated, the direct effect of ethanol 
metabolism seems to be related to ROS production, 
mitochondrial damage and steatosis, which are the common 
features of acute and chronic alcohol exposure [104, 105, 
106]. Studies have demonstrated that enzymatic as well as 
non-enzymatic systems which preserving cellular 
homeostasis is remarkably affected by alcohol in various 
models. 
2. Oxidative Stress Caused by Drugs 
The liver is the most frequently targeted organ in terms of 
drug toxicity. The production of radical species, specifically 
ROS and RNS, has been planned as an early occasion of drugs 
hepatotoxicity and as an indicator of hepatotoxic potential 
[107].It has been discovered that a lot of drugs could 
stimulate oxidative stress including augment of cellular 
oxidants and lipid peroxidation, diminution of antioxidants 
in the liver, such as anti- inflammation drugs, anti-analgesic 
drugs, anti-cancer drugs and antidepressants. For instance, 
sulfasalazine, a drug to treat inflammatory bowel diseases, 
has been found to induce hepatic oxidative damage [108]. 
Oral sulfasalazine administration could diminish superoxide 
dismutase (SOD) activity significantly. In addition, zoledronic 
acid is used to treat the cancer associated hypercalcemia. It 
has been revealed that zoledronic acid significantly elevated 
MDA and nitric oxide levels, while reduced GSH levels, which 
indicated that zoledronic acid could induce oxidative stress 
and decrease antioxidant level in liver [109]. Furthermore, 
paracetamol which is an broadly used analgesic compound in 
mice was evaluated by it induced a notable increase of MDA 
and nitrite as well as nitrate in the liver, with potent 
decrease of total SOD and Cu/Zn-SOD activity [110]. 
3. Oxidative Stress Caused by Environmental Pollutants 
Environmental pollutants such as heavy metals and 
microcystin have been shown to cause oxidative damage in 
liver of animal models. Antioxidant defense system in rat 
liver was damaged after mercury chloride treatment [111]. 
The results showed that low dose of mercury could incur 
oxidative stress and hepatic damage. Besides mercury, lead 
was also found to exacerbate liver lipid peroxidation in 
protein-undernutrited rats, in which the study also 
suggested that free radical is a pathological mechanism for 
hepatotoxicity of lead[112]. 
4. Oxidative Stress Caused by Other Factors 
Other factors such as radiation and temperature may also 
induce hepatic oxidative stress. The oxidative stress induced 
through exposure of mobile phone-like radiation has been 
inspected in the liver of guinea pigs [113]. The results 
showed that after radiation exposure, the levels of MDA and 
total nitric oxide were significantly increased and the 
activities of SOD and glutathione peroxidase (GPx) were 
reduced in the liver of guinea pigs. Additionally, the severity 
of oxidative damage was increased along with the period of 
radiation exposure. Furthermore, study observed that cold 
stress could lead to decrease in CAT, SOD and GSH-Px 
activities in rat liver when the rats were  ept at     C for a 
week, which indicated that cold stress may cause hepatic 
damage which is associated with oxidative stress [114]. 
Moreover, the effect of ZnO2 nanoparticles, a common 
cosmetic constituent, on cellular oxidative stress in mouse 
liver was investigated [115]. After exposure to ZnO2 
nanoparticles, capability of hepatic cells was decreased in 
concentration-dependent manner, and decrease in 
antioxidant enzyme levels as well as increase in DNA adduct. 
Actually, studies have suggested that maternal high-fat diet 
feeding could raise the incidence of metabolism-related 
diseases in offspring, including chronic liver disease. Zhang 
et al. found that maternal high-fat diet increased the level of 
plasma triglyceride and hepatic TBARS significantly [116]. 
The size of lipid droplets in the liver of rat offspring was also 
increased. In another study, the effect of high dietary salt on 
hepatic antioxidant defensing enzyme of fructose-fed rats 
was investigated [117]. Feeding fructose-fed rats with high-
salt diet could trigger hyperinsulinemia and insulin 
resistance resulting in membrane perturbation. This 
potentially enhanced hepatic lipid peroxidation in the 
presence of steatosis, and led to decrease in antioxidant 
defenses, as observed by reduction of GSH, SOD and CAT 
activities. These results indicated that consumption of salt-
rich diet by insulin-resistant subjects could lead to sodium 
reabsorption, which may aggravate hepatic lipid 
peroxidation related to damage antioxidant defenses. 
Antioxidants and natural defense from ROS induced 
damages  
Uncontrolled production of ROS can lead to their gathering 
causing oxidative stress in the cells. Therefore, cells have 
evolved defense mechanisms for protection against ROS 
mediated oxidative damage. These comprise antioxidant 
defenses to maintain a check on the generation of ROS. An 
antioxidant is a substance that is present at small 
concentrations and significantly setbacks or prevents 
oxidation of the oxidizable substrate. Antioxidants are 
effective as they can donate their own electrons to ROS and 
thus neutralizing the adverse effects of the latter. In general, 
an antioxidant in the body may work at three different levels: 
(a) prevention; keeping formation of reactive species to a 
minimum e.g. desferrioxamine (b) interception; scavenging 
reactive species either via using catalytic and non-catalytic 
molecules e.g. ascorbic acid, alpha-tocopherol and (c) repair; 
repairing damaged target molecules e.g. glutathione[118]. 
The antioxidant systems are classified into two major 
groups, enzymatic anti-oxidants and non-enzymatic 
antioxidants. Enzymatic antioxidants present in the body 
include SOD, catalase and GPx that act as body’s first line of 
defense against ROS by catalyzing their conversion to less 
reactive or inert species (Figure 2) [119]. 
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Figure 2.Overview of mechanism of drug and xenobiotic metabolism and effects of herbal antioxidants. 
 
Several low molecular weight molecules present inside the 
cell provide secondary defense against free radicals and act 
as non-enzymatic antioxidants. A few examples of such 
molecules include GSH, α-tocopherol, ascorbate, bilirubin 
[118]. These agents either scavenge the ROS directly or 
prevent the production of ROS through sequestration of 
redox active metals like iron and copper [99].  
Natural products as antioxidants  
Natural products have shown great promise in combating 
against the toxicity of several commonly used drugs, 
including acetaminophen. Additionally, some of these natural 
products, such as resveratrol and curcumin, are now widely 
accepted chemopreventive agents. Due to easy availability 
and dietary nature, it is time to promote the natural products 
as supplementary medication with drugs that also cause 
toxicity to cells. Use of herbs in treatment of various liver 
disorders is common in China. Now these medicines are 
being gradually accepted worldwide, particularly in Asia, 
Europe and North America. Nevertheless, the application 
strategy may differ in East and West due to variety of 
reasons, such as, philosophical viewpoint, concept of 
diseases, and treatment approaches [14]. A variety of dietary 
plants including grams, legumes, fruits, vegetables, tea as 
well as wine contain antioxidants. The prophylactic 
properties of dietary plants have been attributed to the 
antioxidants / polyphenols present in them. Polyphenols 
with over 8000 structural variants are secondary 
metabolites of plants and represent a huge extent of 
substances having aromatic ring(s) bearing one or more 
hydroxyl moieties [99]. Polyphenols are effective ROS 
scavengers and metal chelators because of the presence of 
multiple hydroxyl groups. Examples of polyphenolic natural 
antioxidants derived from plant sources include vitamin E, 
flavonoids, cinnamic acid derivatives, curcumin, caffeine, 
catechins, gallic acid derivatives, salicylic acid derivatives, 
chlorogenic acid, resveratrol, folate, anthocyanins and 
tannins [120]. Apart from polyphenols there are also some 
plant derived non-phenolic secondary metabolites such as 
melatonin, carotenoids, retinal, thiols, jasmonic acid, 
eicosapentaenoic acid, ascopyrones and allicin that show 
excellent antioxidant activity [121,122]. Vitamin C, the water 
soluble natural vitamin, plays a crucial role in regenerating 
lipid soluble antioxidants like vitamin E. Both vitamin E and 
C are used as standards for evaluating the antioxidant 
capacity of new molecules [118]. Noteworthy,  scientists 
suggested a crude classification of herbal drugs in two 
groups; firstly, the main ingredients, for example silybin, 
osthole, cumarin, glycorrhizin, flavonoids and so on; and 
secondly, the supporting substances like sugars, amino acids, 
resins, tannins, and volatile oil.  To declare the subject, figure 
(2) illustrates mechanism of drug and xenobiotic metabolism 
and effects of herbal antioxidants [14].   
Limitations of antioxidant supplementation  
The primary concern regarding antioxidant supplementation 
is their potentially deleterious effects on ROS production 
(pro-oxidant action) especially when precise modulation of 
ROS levels are needed to allow normal cell function [123]. In 
fact, some negative effects of antioxidants when used in 
dietary supplements (flavanoids, carotenoids, vitamin C and 
synthetic compounds) have emerged in the last few decades 
[124]. Mechanistic investigation has revealed that 
antioxidants may exhibit pro-oxidant activity depending on 
the specific set of conditions. Of particular importance are 
their dosage, redox conditions and also the presence of free 
transition metals in cellular environment [125]. For example, 
ascorbate, a well-known antioxidant in the presence of high 
concentration of ferric iron is a potent mediator of lipid 
peroxidation. Recent studies recommend that ascorbate 
sometimes increases DNA damage in humans. Similarly β-
carotene also can behave as a prooxidant in the lungs of 
smokers. Of note, natural antioxidant compounds have 
relatively poor bioavailability. It is therefore necessary to 
take into cognizance the bioavailability and differential 
activities of natural and synthetic antioxidant compounds 
before considering them as therapeutic or pharmacological 
agents [99].  
CONCLUSION 
Several mechanisms are involved in the initiation of liver cell 
damage and aggravate ongoing injury processes. Dysfunction 
Fikry et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):1068-1077 
ISSN: 2250-1177                                                                                  [1074]                                                                                    CODEN (USA): JDDTAO 
of these vital cell organelles results in impairment of 
dynamic equilibrium in homeostatic condition, thus resulting 
in intracellular oxidative stress with excessive formation of 
ROS. Hepatotoxicity remains a major cause of drug 
withdrawal from the market. Natural products have shown 
great promise in combating against the toxicity of several 
commonly used drugs, including acetaminophen. 
Additionally, some of these natural products, such as 
resveratrol and curcumin, are now widely accepted 
chemopreventive agents. Although a majority of natural 
products investigated to date are non-toxic, some studies 
have shown liver toxicity by certain natural products. 
Therefore, the proper selection of the natural products is 
also necessary. 
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